Aspiriant LLC’s VanEck Morningstar Wide Moat ETF MOAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,415
Closed -$1.21M 315
2024
Q1
$1.21M Buy
13,415
+4,785
+55% +$411K 0.05% 133
2023
Q4
$732K Hold
8,630
0.03% 165
2023
Q3
$654K Buy
8,630
+3,875
+81% +$309K 0.03% 163
2023
Q2
$379K Buy
+4,755
New +$358K 0.02% 199

Other funds holding MOAT

Aspiriant LLC's MOAT Position: Q2 2024 in Review

Aspiriant LLC sold out of VanEck Morningstar Wide Moat ETF (MOAT) in Q2 2024, closing a stake of 13,415 shares — an estimated $1.21M sold.

Aspiriant LLC first reported a position in MOAT in Q2 2023 and held it in 4 quarters. The position peaked at $1.21M in Q1 2024. 658 funds tracked by Wall St. Rank hold MOAT as of Q2 2024.

  • Aspiriant LLC reported no remaining VanEck Morningstar Wide Moat ETF position as of Q2 2024 after selling out during the quarter.
  • Aspiriant LLC sold 13,415 VanEck Morningstar Wide Moat ETF shares in Q2 2024, an estimated $1.21M.
  • Aspiriant LLC first reported a position in VanEck Morningstar Wide Moat ETF in Q2 2023 and held it in 4 quarters.
  • Aspiriant LLC's VanEck Morningstar Wide Moat ETF position peaked at $1.21M in Q1 2024.
  • 658 funds tracked by Wall St. Rank held VanEck Morningstar Wide Moat ETF as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.